KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest Income - NetInterest Income - TotalNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRevenueShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateWages, Salaries and Other
Others
Ratios

Community Health Systems (CYH) Shares Outstanding (Weighted Average) (2016 - 2025)

Community Health Systems (CYH) has disclosed Shares Outstanding (Weighted Average) for 11 consecutive years, with $133.8 million as the latest value for Q3 2025.

  • For the quarter ending Q3 2025, Shares Outstanding (Weighted Average) rose 1.07% year-over-year to $133.8 million, compared with a TTM value of $133.8 million through Sep 2025, up 1.07%, and an annual FY2024 reading of $132.1 million, changed N/A over the prior year.
  • Shares Outstanding (Weighted Average) was $133.8 million for Q3 2025 at Community Health Systems, roughly flat from $133.8 million in the prior quarter.
  • Across five years, Shares Outstanding (Weighted Average) topped out at $133.8 million in Q3 2025 and bottomed at $126.8 million in Q4 2021.
  • Average Shares Outstanding (Weighted Average) over 4 years is $130.4 million, with a median of $131.8 million recorded in 2024.
  • The sharpest move saw Shares Outstanding (Weighted Average) rose 10.73% in 2021, then rose 1.07% in 2025.
  • Year by year, Shares Outstanding (Weighted Average) stood at $126.8 million in 2021, then increased by 1.62% to $128.8 million in 2022, then increased by 2.56% to $132.1 million in 2024, then grew by 1.28% to $133.8 million in 2025.
  • Business Quant data shows Shares Outstanding (Weighted Average) for CYH at $133.8 million in Q3 2025, $133.8 million in Q2 2025, and $132.1 million in Q4 2024.